Study probes COVID-19 immune response in arthritis patients on immunosuppressants
NCT ID NCT04584541
First seen Apr 01, 2026 · Last updated May 29, 2026 · Updated 7 times
Summary
This study looked at how immunosuppressive drugs used for rheumatoid arthritis and spondyloarthritis affect the body's ability to fight COVID-19. Researchers compared 150 patients on these medications with infected family members not on the drugs. The goal was to measure virus levels and immune responses, including antibodies and T-cells, to see if the medications weaken the body's defense against the virus.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cochin hospital
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.